Dimitris Voliotis
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Dimitris Voliotis
The proxy statement of Zentalis Pharmaceuticals, Inc. reports total compensation of $1,382,546 for Dimitris Voliotis in fiscal 2021, including a base salary of $472.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Zentalis Pharmaceuticals, Inc. (ZNTL)
Proxy statement
Start not stated–2022-04-28
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Zentalis Pharmaceuticals, Inc. (ZNTL) | SVP, Clinical Development | $472 | $1,382,546 |
Recent activity
No call appearances or filed executive changes recorded yet.